Mechanisms of Protection against Clostridium difficile Infection by the Monoclonal Antitoxin Antibodies Actoxumab and Bezlotoxumab
Zhiyong Yang(Unknown), Hanping Feng(Chinese Academy of Sciences), Therwa Hamza(University of Maryland, Baltimore), Wolfgang Seghezzi, Harris G. Yfantis(University of Maryland, Baltimore), Jeremy P. Ramsey(University of Maryland, Baltimore), Alex G. Therien(Merck Canada Inc. (Canada)), Dong Ki Lee(Yonsei University), Lorraine D. Hernandez(Merck & Co., Inc., Rahway, NJ, USA (United States)), Shan Li(Jiangnan University), Yongrong Zhang(University of Maryland, Baltimore), Nicole M. Davis(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jamie M. Furneisen(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 97
Related Papers
Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
|Cancer Research|2008|708
Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
|Cancer Research|2008|522
Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS‐4 and ADAMTS‐5
|Arthritis & Rheumatism|2007|403